Literature DB >> 15205715

Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in community dwelling postmenopausal Hungarian women.

H P Bhattoa1, P Bettembuk, S Ganacharya, A Balogh.   

Abstract

Hypovitaminosis D can result in low bone mass. The prevalence of hypovitaminosis D has public health implications, especially where data are lacking. Since diet and sunlight are the two souces of vitamin D, the results obtained in one geographical region may not be universally applicable. The aim of this study is to characterize the prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in community dwelling postmenopausal Hungarian women. We determined serum levels of 25-hydroxyvitamin D (25-OH-D), PTH, osteocalcin (OC), degradation products of C-terminal telopeptides of type-I collagen (CTx), dietary calcium intake and BMD at L2-L4 lumbar spine (LS) and femur neck (FN) in 319 randomly selected ambulatory postmenopausal women. The prevalence of hypovitaminosis D (serum 25-OH-D< or =50 nmol/l) was 56.7%. On comparing patients with normal and low 25-OH-D, a significant difference was found in age (61.6+/-8.5 years versus 67.3+/-9.9 years; P<0.001), PTH (3.9+/-1.9 pmol/l versus 4.3+/-2.7 pmol/l; P<0.05), FN BMD (0.802+/-0.123 g/cm(2) versus 0.744+/-0.125 g/cm(2); P<0.001) and dietary calcium intake (714.4+/-199.4 g/day versus 607.9+/-233 g/day; P<0.001). Osteoporotic patients had a significantly lower 25-OH-D (37.6+/-19.8 nmol/l versus 56.4+/-24 nmol/l; P<0.001) and dietary calcium intake (519.2+/-244.5 mg/day versus 718.2+/-164.3 mg/day; P<0.001). After controlling for all other variables, 25-OH-D was found to be significantly associated with age, the average hours of sunshine in the 3 months prior to 25-OH-D level determination and dietary calcium intake ( r(2)=0.190; P<0.001). For FN BMD, significant independent predictors were age, body mass index, 25-OH-D and dietary calcium intake ( r(2)=0.435; P<0.001). The prevalence of hypovitaminosis D during spring, summer, autumn and winter was 71%, 46.3%, 49.4% and 56.7%, respectively. There was significant seasonal variation in 25-OH-D, PTH, OC, calcium intake and FN BMD. There is a high prevalence of hypovitaminosis D in healthy postmenopausal Hungarian women, and FN BMD is associated with serum 25-OH-D and dietary calcium intake.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15205715     DOI: 10.1007/s00198-003-1566-1

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  25 in total

1.  Bone density parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women.

Authors:  K T Khaw; M J Sneyd; J Compston
Journal:  BMJ       Date:  1992-08-01

2.  The diagnosis of osteoporosis.

Authors:  J A Kanis; L J Melton; C Christiansen; C C Johnston; N Khaltaev
Journal:  J Bone Miner Res       Date:  1994-08       Impact factor: 6.741

3.  Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women.

Authors:  P Mezquita-Raya; M Muñoz-Torres; J D Luna; V Luna; F Lopez-Rodriguez; E Torres-Vela; F Escobar-Jiménez
Journal:  J Bone Miner Res       Date:  2001-08       Impact factor: 6.741

Review 4.  Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications.

Authors:  P Lips
Journal:  Endocr Rev       Date:  2001-08       Impact factor: 19.871

5.  Low vitamin D status is common among elderly Dunedin women.

Authors:  K A McAuley; S Jones; N J Lewis-Barned; P Manning; A Goulding
Journal:  N Z Med J       Date:  1997-07-25

6.  Determination of serum 25-hydroxyvitamin D(3) levels in early postmenopausal Iranian women: relationship with bone mineral density.

Authors:  A Rassouli; I Milanian; M Moslemi-Zadeh
Journal:  Bone       Date:  2001-11       Impact factor: 4.398

Review 7.  NIH Consensus conference. Optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake.

Authors: 
Journal:  JAMA       Date:  1994-12-28       Impact factor: 56.272

8.  Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women.

Authors:  M E Ooms; P Lips; J C Roos; W J van der Vijgh; C Popp-Snijders; P D Bezemer; L M Bouter
Journal:  J Bone Miner Res       Date:  1995-08       Impact factor: 6.741

9.  Nutritional status in a healthy elderly population: vitamin D.

Authors:  J L Omdahl; P J Garry; L A Hunsaker; W C Hunt; J S Goodwin
Journal:  Am J Clin Nutr       Date:  1982-12       Impact factor: 7.045

10.  Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans.

Authors:  R Marcus; P Madvig; G Young
Journal:  J Clin Endocrinol Metab       Date:  1984-02       Impact factor: 5.958

View more
  28 in total

1.  Overcoming resistance to bisphosphonates through the administration of alfacalcidol: results of a 1-year, open follow-up study.

Authors:  János Gaál; Tamás Bender; József Varga; Irén Horváth; Judit Kiss; Péter Somogyi; Péter Surányi
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

Review 2.  Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in healthy Hungarian men over 50 years of age: the HunMen Study.

Authors:  H P Bhattoa; E Nagy; C More; J Kappelmayer; A Balogh; E Kalina; P Antal-Szalmas
Journal:  Osteoporos Int       Date:  2012-03-16       Impact factor: 4.507

3.  Changes in vitamin D supplement use and baseline plasma 25-hydroxyvitamin D concentration predict 5-y change in concentration in postmenopausal women.

Authors:  Melissa A Kluczynski; Jean Wactawski-Wende; Mary E Platek; Carol A DeNysschen; Kathleen M Hovey; Amy E Millen
Journal:  J Nutr       Date:  2012-07-25       Impact factor: 4.798

4.  Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and vitamin D receptor genotypes in healthy Saudi pre- and postmenopausal women.

Authors:  M-S M Ardawi; M H Qari; A A Rouzi; A A Maimani; R M Raddadi
Journal:  Osteoporos Int       Date:  2010-04-30       Impact factor: 4.507

5.  Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial.

Authors:  Amy E Millen; Jean Wactawski-Wende; Mary Pettinger; Michal L Melamed; Frances A Tylavsky; Simin Liu; John Robbins; Andrea Z LaCroix; Meryl S LeBoff; Rebecca D Jackson
Journal:  Am J Clin Nutr       Date:  2010-03-10       Impact factor: 7.045

6.  The problem of low levels of vitamin D and osteoporosis: use of combination therapy with alendronic acid and colecalciferol (vitamin D3).

Authors:  Sol Epstein
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

7.  High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors.

Authors:  M Z Erkal; J Wilde; Y Bilgin; A Akinci; E Demir; R H Bödeker; M Mann; R G Bretzel; H Stracke; M F Holick
Journal:  Osteoporos Int       Date:  2006-05-23       Impact factor: 4.507

Review 8.  Vitamin D and neurocognitive dysfunction: preventing "D"ecline?

Authors:  Jennifer S Buell; Bess Dawson-Hughes
Journal:  Mol Aspects Med       Date:  2008-05-13

9.  Seasonality of hip fractures and estimates of season-attributable effects: a multivariate ARIMA analysis of population-based data.

Authors:  H-C Lin; S Xiraxagar
Journal:  Osteoporos Int       Date:  2006-02-21       Impact factor: 4.507

Review 10.  Vitamin D status in gastrointestinal and liver disease.

Authors:  Helen M Pappa; Elana Bern; Daniel Kamin; Richard J Grand
Journal:  Curr Opin Gastroenterol       Date:  2008-03       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.